Company intelligence / Profile preview
Monopteros Therapeutics Inc.
Boston, Massachusetts, United Statespharmaceutical-technology.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Phase 1
01
Overview
Monopteros Therapeutics has initiated a Phase 1/1b open-label, dose-escalation and cohort expansion study of its lead candidate MPT‑0118 as monotherapy and in combination with pembrolizumab for patients with advanced or metastatic refractory solid tumors. The company’s approach aims to reprogram immunosuppressive regulatory T cells within the tumor microenvironment to enhance response to immune checkpoint therapy. Translational nonclinical results have shown that this mechanism can convert “cold” tumors into ones responsive to immunotherapy.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule inhibitor (MALT1 inhibitor)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Medicxi (investor/backer)
Beyond the preview
Go deeper on Monopteros Therapeutics Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Monopteros Therapeutics Inc..